Background
Non-alcoholic fatty liver diseases (NAFLD) are characterized by triglyceride accumulation in hepatocytes (i.e., liver steatosis). In some cases, steatosis becomes complicated by inflammation and can evolve to apoptosis, necrosis and fibrosis. This association of steatosis to other lesions is called non-alcoholic steatohepatitis or NASH [
1], and may evolve into cirrhosis and hepatocellular carcinoma.
NASH is a disease of emerging importance and is now considered as the most common cause of chronic liver disease in the USA [
2,
3]. While the pathogenesis of NASH is poorly understood, the hypothesis of two "hits" is recognized [
4]. Fat accumulation in the liver represents the "first hit". The factor responsible for the second "hit" is hepatic oxidative stress due to ROS emission and/or increased cytokine release, enhancing lipid peroxidation, mitochondrial DNA and respiratory chain damages [
5,
6]. Currently, no defined therapy is known to alter the course of NASH [
5,
7‐
10].
The study of the pathogenic factor involved in NASH is difficult because of the lack of a suitable experimental animal model [
11]. Currently, available animal models are rodents either with a genetic defect (ob/ob mice or Fa/Fa rat) [
12] or fed a methionine and choline deficient diet (MCD diet) [
13]. The latter model is commonly used but induces a nutritional deficiency that is not observed in patients with NASH. The major disadvantage of these models is that they fail to reflect the multi-factorial features of NASH observed in patients. High caloric intake and obesity are factors frequently associated with NASH in humans. In rodents, however, the situation is less clear as rats fed high fat diets were shown to develop hepatic steatosis in some studies [
14‐
16] but not in others [
17,
18]. Comparisons of the protocols used showed that the composition and the palatability of the diets may play an important role in the development of the obesity and NASH. To overcome these difficulties, some authors gave diet ad libitum while others strictly controlled the caloric intake through intragastric diet infusion or force-feeding. Lieber et al. used a liquid high fat diet given ad libitum to rats [
19] whereas Zou et al. controlled daily fat intake by force-feeding rats [
20]. In these two cases, high fat diet induced mild steatosis (two fold increase in hepatic triacylglycerol compared to control) and huge hepatic inflammation. The main fat component of these two diets was corn oil, (consisted of 13% (w/w) saturated fatty acid (SFA), 24% monounsaturated fatty acid (MUFA) and 59% polyunsaturated fatty acid (PUFA)). These PUFA were almost entirely composed by pro-inflammatory n-6 polyunsaturated fatty acids which are known to be involved in liver oxidative stress [
21]. These models do not really mimic human NASH diet features since a study reported that patients with NASH usually have a diet with higher levels of SFA (13.7% instead of 10.0% total kcal) and cholesterol, and low levels of PUFA (3.5% (w/w) [
22].
Consequently, to analyse NASH pathogenesis, the aims of the present study were (i) to study the development of steatosis following a SFA-rich diet, ii) to study the possible evolution from steatosis to NASH and iii) to determine the possible liver adaptations to this new condition. We tested two high saturated fat diets with either coconut oil, which contains roughly 86% SFA, or butter, which contains 51% SFA. These diets were compared with the MCD diet, the most common diet used to mimic NASH in rodents.
Discussion
In rodents, we succeeded in increasing lipid and caloric intake by a very large amount with an ad libitum access to diet. Nevertheless, this nutritional manipulation did not reproduce the typical hepatic lesion of NASH, i.e. steatosis, inflammation and fibrosis. No accumulation of triacylglycerols was observed in the liver of rats fed coconut oil containing 90% of SFA or butter with 51% of SFA. Such ability to overcome excessive energy intake may be related to rat ability to dissipate excess energy as heat. It is particularly true for young rats that resist becoming obese when fed a cafeteria-diet by increasing energy expenditure [
33] through thermogenic processes occurring in liver [
34] and BAT [
35]. Our results show that, in rats fed a high fat diet, the ability of the liver to oxidize fatty acid, as assessed by i) ketone body formation, and ii) hepatocyte and mitochondrial respiration, is not enhanced. In our model, the liver of Wistar rats appears very mildly affected by an overload in lipid intake and we can assume that fatty acid exportation from the liver is sufficient to favour peripheral storage. High fat feeding probably induced an increased capacity to export triacylglycerol in the form of VLDL. Indeed it has been shown that feeding a diet with 20% hydrogenated coconut oil was shown to increase VLDL and LDL levels by 15–17% in rats and by 44% in mice. Furthermore plasma ApoE and ApoB were increased while hepatic ApoE mRNA and ApoB mRNA were unchanged [
36]. Moreover, in our study, the high fat fed rats had increased white adipose tissue mass, which is in accordance with a higher triacylglycerol export from the liver to the adipose tissue. Similarly, feeding rats with various high fat diets (coconut oil, olive oil, menhaden oil, etc.) was shown to increase their epididymal fat mass [
37‐
39]. However, we noted that fat accumulation in white adipose tissue was different depending on the type of fatty acid in the diets, and more precisely the length of the carbon chain. Indeed, coconut oil rich in medium chain saturated fat (mainly: lauric acid; C12:0; 44.6%) led to a lower peripheral accumulation than butter diet rich in longer chain saturated fat (mainly palmitic acid; C16:0; 21.7%). Many studies demonstrated that medium chain triglycerides (MCTs), such as in coconut oil, cause significant reduction in body weight or fat pad size in animals and humans [
40‐
42]. This reduction of fat pad could be explained by the fact that MCT are transported directly to the liver
via the portal vein and thus do not pass the adipose tissue before hepatic disposal. These characteristics could be responsible for the different rates of MCT oxidation versus LCT [
43], and then could partly account for the difference in fat accumulation observed in white adipose tissue.
Another way to explain the lack of hepatic steatosis during lipid overload is peripheral utilisation. Mammals possess specialised thermogenic BAT that is characterized by a high amount of mitochondria containing high levels of UCP1, an uncoupling protein, located in the mitochondrial inner membrane [
44]. UCP activation (by coldness or diet) results in the uncoupling of substrate oxidation from ADP phosphorylation [
45], with a resultant increase in heat production [
44]. In that thermogenic process, fatty acids act not solely as substrates for β-oxidation but are also involved in the uncoupling process by activating UCP1 transcription and activity [
46]. UCP1 expression is regulated by a fatty acid activated transcriptional factor: peroxisome proliferator-activated receptor (PPAR) [
47]. In our study interscapular BAT is larger, or tends to be larger, in the high fat fed groups, concomitantly with and increased content in UCP1, suggesting the implication of this tissue in fatty acid oxidation. BAT thermogenesis and UCP1 expression are known to increase during high-fat feeding, possibly to dissipate energy and to regulate body weight [
35,
47‐
49]. We can therefore postulate that rats can adapt to excessive lipid ingestion: firstly, by increasing the storage of fatty acids in peripheral white adipose tissues, and secondly by over-expressing the UCP1-related thermogenesis in BAT.
At this time, the reference model for the study of NASH is the MCD diet [
31,
32]. We confirm here that such diet induces a striking steatosis, demonstrated by a massive increase in hepatic triacylglycerol content. In the MCD diet-fed rats, steatohepatitis is the consequence of both the high-fat content and the methionine and choline deficiency. The lack of methionine reduces glutathione synthesis and impairs antioxidant defences against radical attacks. In addition, the choline deficiency impairs lipid exportation by decreasing the phosphatidylcholine synthesis, leading to a reduction in the fatty acid export from the liver [
50]. The fact that, after an MCD diet, the high steatosis is associated with the blocking of the lipid export from the liver consorts with our hypothesis that, in our study, high-fat fed rats are resistant to liver injury thanks to a very efficient lipid exportation. Apart from steatohepatitis, the key feature of human NASH, the MCD diet fails to induce the other characteristics of NASH, i.e. abdominal obesity and increased calorie intake. Therefore, the MCDD model is adequate to study the consequence of fat accumulation and inflammation in hepatocytes but is inadequate to study the pathogenesis of steatohepatitis.
In this work, to mimic the diet habits of NASH patients [
22], we realised a high fat diet with high level of medium chain SFA (i.e., coconut oil or butter). However, in rats, high fat diet with SFA (51% or 86%) was not efficient to induce steatosis or steatohepatitis. The comparison between the different high fat diet in Table
4[
20,
51‐
54], showed that there was a large variation in fat quantity in the regimens used in several studies. Surprisingly, it was not the diet with the higher percentage of fat that induced the most striking steatosis. The fattiest diets with 35–49% of lipid (w/w) (our model and the Lieber's or Zou's diets [
20,
53]) did not always induce steatosis or only a mild one (two fold increase as compared to their control). By contrast, a diet with "only" 10% of fat (w/w) developed steatosis and inflammation [
54]. There is considerable evidence that the type and not the proportion of fat in a diet is a key determinant of fat accumulation and lesions in liver disease. Another interesting point was the percentage and the type of carbohydrates present in the diet. Indeed, increased dietary supply of carbohydrate could promote steatosis by increasing hepatic lipid uptake or
de novo synthesis. Many studies showed that high sucrose supply induced obesity, insulino-resistance and steatosis in rodents [
11,
55‐
58]. Diets that were enriched with comparable amount of glucose or glycerol did not produce any over hepatic pathology. Surprisingly, in the studies presented in Table
4, steatosis was not always correlated with the presence of sucrose in the diet [
20,
59]. More studies are therefore needed to clarify the possible links between lipids and carbohydrates in NASH pathogenesis.
Table 4
Lipid characteristics of high fat diets used to induce steatosis and steatohepatitis
Rat
| Wistar | Wistar | Sprague Dawley | Sprague Dawley | Wistar | Sprague Dawley | Sprague Dawley |
Fat (w/w)
| 45% coconut | 45% butter | 30.1% corn oil 17.6% olive oil 1.7% safflower oil | 35.7% corn oil | 15% corn oil | 3.4% corn oil 14.6% lard | 10% lard oil 2% cholesterol |
SFA (% fat)
| 86.5 | 51.3 | 13 | 13 | 13 | 34 | 39 |
MUFA (% fat)
| 5.8 | 21 | 41 | 24 | 27.6 | 42 | 45 |
PUFA (% fat)
| 1.8 | 3 | 42 | 59 | 54.7 | 20 | 21 |
Carbohydrate (w/w)
| 24.7% corn starch | 16.2% dextrin maltose | 13.4% sucrose | 50% sucrose | 39% corn starch | nd |
Time of diet (week)
| 14 | 14 | 3 | 6 | 6 | 8 | 16 | 12 |
steatosis
| no | no | mild | mild | no | yes | yes | yes |
inflammation
| no | no | yes | yes | no | nd | nd | mild |
fibrosis
| no | no | yes | nd | no | nd | nd | no |
The lipid composition of the different diets which induce steatohepatitis (see Table
4) [
19,
20,
51,
52,
54], were lard and corn oil, both oils rich in unsaturated fatty acids. We can observe that fat of all the diets inducing steatosis and inflammation (Table
4) were richer in MUFA and PUFA (>30% and >20% of total fat respectively) as compared to our diet (5% and 2%). The injurious effect of unsaturated fatty acids, and particularly n-6 polyunsaturated fatty acids, was associated with enhanced lipid peroxidation and decreased concentrations of antioxidant enzymes, implicating oxidative stress as a causal factor. Indeed, different studies showed the pro-inflammatory effect of polyunsaturated n-6 fatty acids which exacerbate liver oxidative stress [
60,
61] and promote the development of NASH.
During the two last century, in Western diets, there has been a huge increase in n-6 fatty acid consumption and, the ratio of n-6 over n-3 fatty acids has increased from 1:1 to 15–20:1 [
61,
62]. Arachidonic acid (n-6) and eicosapentanoic acid (n-3) are precursors for the production of eicosanoids, and have opposite metabolic effects. Cardiovascular diseases, diabetes, obesity, cancer and other pathologies are associated with increased production of thromboxane A2, leukotriene B4, Il-1β, IL-6 and TNF. All these factors increase consequently to a rise in n-6 fatty acid intake and decrease with a higher n-3 fatty acid intake [
63]. Different studies showed the pro-inflammatory effect of polyunsaturated n-6 fatty acids which exacerbate liver oxidative stress [
63,
64] and promote the development of NASH. It follows that the development of steatohepatitis with high fat diet in rats may be facilitated by the use of MUFA and PUFA, especially n-6 fatty acid, than SFA. However, these results contradict the observations made in humans where the daily intake of PUFA is around 5% (w/w) in the general population and 3.5% in NASH patients [
22]. A high fat diet with saturated fatty acids is not sufficient to induce a steatosis and then a steatohepatitis. A number of studies showed, that it may be more suitable to use a high mono- and polyunsaturated fatty acid diet to induce NASH in rats. It appears here that the key factor could be the possible induction of the lipid peroxidation and pro-inflammatory cytokine production by the high level of PUFA leading to steatosis and inflammation. Another possibility is that Wistar rat is not a suitable model to study obesity and pathologic modifications in the liver consecutively to a modification of the diet [
65].
Competing interests
The author(s) declare that they have no competing interests.
Authors' contributions
CR carried out the various experiments, participated in the design of the study and drafted the manuscript; CR, BS and EB performed animals and biochemical studies; VR, MD and IO performed histological analysis; CF and CD also helped in drafting manuscript; MAP and BS participated in the design of the study and helped to draft the manuscript. All authors read and approved the final manuscript.